Top 10 Key Players companies in Dengue vaccine by Highest Patent Value in the world in 2022 – Discovery

Free Trial

The Dengue vaccine top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Dengue vaccine Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Visterra, Inc.	Massachusetts, United States	Clinical trial,Pharmacy and Therapeutics,Glycobiology, ...[+2]	Avg patent value: 5.18 M
2	The Chemo-Sero-Therapeutic Research Institute	Kumamoto, Japan	Blood plasma,Medicine,Suture (anatomy), ...[+2]	Avg patent value: 1.56 M
3	GlaxoSmithKline Biologicals SA	Belgium	Medicine,Rubella,Hepatitis, ...[+2]	Avg patent value: 1.31 M
4	Merck & Co., Inc.	New Jersey, United States	Health care,Biopharmaceutical,Drug, ...[+2]	Avg patent value: 1.18 M
5	Merck Sharp & Dohme Corp.	New Jersey, United States	Prescription drug,Medicine,Stroke, ...[+2]	Avg patent value: 1.18 M
6	GenVec, Inc.	United States	Medicine,Pharmacy and Therapeutics,Gene delivery, ...[+2]	Avg patent value: 340,000
7	Panacea Biotec Ltd.	Delhi, India	Medicine,Health care,Biotechnology, ...[+2]	Avg patent value: 310,000
8	Chengdu Institute of Biological Products	Sichuan Sheng, China	Biological product,Medicine,Conjugate vaccine, ...[+2]	Avg patent value: 79,500
9	Takeda Vaccines, Inc.	MT, US	Biotechnology,Agriculture,Fishery, ...[+2]	Avg patent value: 69,740
10	Sanofi Pasteur SA	Rhône-Alpes, France	Health care,Poliomyelitis,Typhoid fever, ...[+2]	Avg patent value: 66,000